FCF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.999800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.845400E-01
Normal-vs-Stage2
9.486000E-01
Normal-vs-Stage3
1.663970E-01
Normal-vs-Stage4
4.110000E-01
Stage1-vs-Stage2
4.819000E-01
Stage1-vs-Stage3
2.747000E-01
Stage1-vs-Stage4
1.325610E-01
Stage2-vs-Stage3
1.547780E-01
Stage2-vs-Stage4
2.242600E-01
Stage3-vs-Stage4
9.648100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.656000E-01
Normal-vs-AfricanAmerican
6.930000E-01
Normal-vs-Asian
3.586800E-01
Caucasian-vs-AfricanAmerican
5.415000E-01
Caucasian-vs-Asian
4.490300E-02
AfricanAmerican-vs-Asian
4.692200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.560600E-01
Normal-vs-Female
9.522800E-01
Male-vs-Female
6.550200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.789400E-01
Normal-vs-Age(41-60Yrs)
6.079000E-01
Normal-vs-Age(61-80Yrs)
8.290800E-01
Normal-vs-Age(81-100Yrs)
8.750800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.942400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.447800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.955600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.567810E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.161400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.819400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.192800E-01
Normal-vs-Daily Drinker
7.133600E-01
Normal-vs-Weekly Drinker
9.995400E-01
Normal-vs-Occasional Drinker
5.198600E-01
Normal-vs-Social Drinker
9.225000E-01
Non Drinker-vs-Daily Drinker
8.635600E-01
Non Drinker-vs-Weekly Drinker
5.417800E-01
Non Drinker-vs-Occasional Drinker
2.621700E-02
Non Drinker-vs-Social Drinker
2.661200E-01
Daily Drinker-vs-Weekly Drinker
5.955800E-01
Daily Drinker-vs-Occasional Drinker
6.632300E-02
Daily Drinker-vs-Social Drinker
3.973200E-01
Weekly Drinker-vs-Occasional Drinker
4.041200E-01
Weekly Drinker-vs-Social Drinker
9.133000E-01
Occasional Drinker-vs-Social Drinker
3.263400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.514400E-01
Normal-vs-Grade 2
8.290200E-01
Normal-vs-Grade 3
7.464200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.826400E-02
Grade 1-vs-Grade 3
7.984300E-03
Grade 1-vs-Grade 4
9.514400E-01
Grade 2-vs-Grade 3
1.000220E-01
Grade 2-vs-Grade 4
8.290200E-01
Grade 3-vs-Grade 4
7.464200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.793800E-01
Normal-vs-NonDiabetic
9.247600E-01
Diabetic-vs-NonDiabetic
8.716800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.435800E-01
Normal-vs-NoPancreatitis
9.980600E-01
Pancreatitis-vs-NoPancreatitis
1.898360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.716400E-01
Normal-vs-N1
8.948200E-01
N0-vs-N1
1.674780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.465800E-01
Normal-vs-TP53-NonMutant
8.192400E-01
TP53-Mutant-vs-TP53-NonMutant
6.550800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
